HEPA - Hepion Pharma announces restructuring plan sees $400-800 thousand charge for 4Q
2023-12-07 08:35:58 ET
More on Hepion
- Hepion to sell $5M in shares through registered direct offering
- Seeking Alpha’s Quant Rating on ContraVir
- Historical earnings data for ContraVir
- Financial information for ContraVir
For further details see:
Hepion Pharma announces restructuring plan, sees $400–800 thousand charge for 4Q